Credit Suisse’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-28,446
| Closed | -$318K | – | 3073 |
|
|
2023
Q3 | $318K | Sell |
28,446
-5,176
| -15% | -$57.8K | ﹤0.01% | 2904 |
|
|
2023
Q2 | $720K | Buy |
33,622
+5,147
| +18% | +$110K | ﹤0.01% | 2584 |
|
|
2023
Q1 | $1.15M | Buy |
28,475
+5
| +0% | +$202 | ﹤0.01% | 2224 |
|
|
2022
Q4 | $1.32M | Buy |
28,470
+702
| +3% | +$32.7K | ﹤0.01% | 2128 |
|
|
2022
Q3 | $1.44M | Buy |
27,768
+3,853
| +16% | +$200K | ﹤0.01% | 2048 |
|
|
2022
Q2 | $1.13M | Buy |
23,915
+2,531
| +12% | +$120K | ﹤0.01% | 2290 |
|
|
2022
Q1 | $1.52M | Sell |
21,384
-197
| -0.9% | -$14K | ﹤0.01% | 2253 |
|
|
2021
Q4 | $1.61M | Sell |
21,581
-784
| -4% | -$58.6K | ﹤0.01% | 2281 |
|
|
2021
Q3 | $1.27M | Sell |
22,365
-1,223
| -5% | -$69.4K | ﹤0.01% | 2425 |
|
|
2021
Q2 | $1.04M | Sell |
23,588
-1,319
| -5% | -$58K | ﹤0.01% | 2606 |
|
|
2021
Q1 | $1.23M | Sell |
24,907
-12,930
| -34% | -$637K | ﹤0.01% | 2462 |
|
|
2020
Q4 | $1.59M | Buy |
37,837
+2,892
| +8% | +$122K | ﹤0.01% | 2276 |
|
|
2020
Q3 | $1.6M | Buy |
34,945
+386
| +1% | +$17.7K | ﹤0.01% | 1963 |
|
|
2020
Q2 | $1.74M | Buy |
34,559
+20,307
| +142% | +$1.02M | ﹤0.01% | 1957 |
|
|
2020
Q1 | $734K | Sell |
14,252
-7,580
| -35% | -$390K | ﹤0.01% | 2324 |
|
|
2019
Q4 | $1.35M | Buy |
21,832
+2,138
| +11% | +$132K | ﹤0.01% | 2326 |
|
|
2019
Q3 | $1.18M | Sell |
19,694
-2,873
| -13% | -$173K | ﹤0.01% | 2300 |
|
|
2019
Q2 | $1.91M | Buy |
22,567
+1,132
| +5% | +$95.6K | ﹤0.01% | 1961 |
|
|
2019
Q1 | $2.05M | Sell |
21,435
-6,065
| -22% | -$579K | ﹤0.01% | 1875 |
|
|
2018
Q4 | $1.95M | Sell |
27,500
-4,387
| -14% | -$311K | ﹤0.01% | 1827 |
|
|
2018
Q3 | $2.72M | Buy |
31,887
+1,244
| +4% | +$106K | ﹤0.01% | 1756 |
|
|
2018
Q2 | $3.55M | Buy |
30,643
+1,849
| +6% | +$214K | ﹤0.01% | 1674 |
|
|
2018
Q1 | $2.33M | Buy |
28,794
+216
| +0.8% | +$17.5K | ﹤0.01% | 1952 |
|
|
2017
Q4 | $1.68M | Sell |
28,578
-3,416
| -11% | -$200K | ﹤0.01% | 2145 |
|
|
2017
Q3 | $1.5M | Buy |
31,994
+3,343
| +12% | +$157K | ﹤0.01% | 2364 |
|
|
2017
Q2 | $1.03M | Sell |
28,651
-17,807
| -38% | -$641K | ﹤0.01% | 2325 |
|
|
2017
Q1 | $1.43M | Buy |
46,458
+11,516
| +33% | +$355K | ﹤0.01% | 2270 |
|
|
2016
Q4 | $1.17M | Buy |
34,942
+7,015
| +25% | +$235K | ﹤0.01% | 2578 |
|
|
2016
Q3 | $744K | Buy |
27,927
+362
| +1% | +$9.64K | ﹤0.01% | 2868 |
|
|
2016
Q2 | $607K | Sell |
27,565
-6,322
| -19% | -$139K | ﹤0.01% | 3004 |
|
|
2016
Q1 | $995K | Buy |
33,887
+16,971
| +100% | +$498K | ﹤0.01% | 2454 |
|
|
2015
Q4 | $558K | Buy |
16,916
+806
| +5% | +$26.6K | ﹤0.01% | 3072 |
|
|
2015
Q3 | $581K | Sell |
16,110
-29,000
| -64% | -$1.05M | ﹤0.01% | 3090 |
|
|
2015
Q2 | $2.03M | Buy |
45,110
+14,732
| +48% | +$663K | ﹤0.01% | 2320 |
|
|
2015
Q1 | $929K | Buy |
30,378
+11,765
| +63% | +$360K | ﹤0.01% | 2780 |
|
|
2014
Q4 | $947K | Sell |
18,613
-475
| -2% | -$24.2K | ﹤0.01% | 2840 |
|
|
2014
Q3 | $755K | Buy |
19,088
+483
| +3% | +$19.1K | ﹤0.01% | 2934 |
|
|
2014
Q2 | $802K | Buy |
18,605
+8,007
| +76% | +$345K | ﹤0.01% | 3077 |
|
|
2014
Q1 | $424K | Buy |
10,598
+937
| +10% | +$37.5K | ﹤0.01% | 3471 |
|
|
2013
Q4 | $264K | Buy |
+9,661
| New | +$264K | ﹤0.01% | 3720 |
|